CD44: From diagnosis to therapy in the journey of oral cancer

Highlights: • Advancements in OSCC treatment have not reduced mortality due to challenges in early diagnosis, highlighting the need for prognostic biomarkers. • CSCs in OSCC fuel chemo-radio-resistance, making their targeting crucial. • CD44, a CSC biomarker, drives cancer progression and resistanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Selvaraj Jayaraman, Vishnu Priya Veeraraghavan
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Oral Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024003297
Tags: Add Tag
No Tags, Be the first to tag this record!